SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Paramount Global (VIACA) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 30/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VIACA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.75
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-9.30
Book Value / Share$0.00
Revenue / Share$44.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$2.89 |
$13.89B |
$1.41B |
10.2% |
| 2016 |
$2.81 |
$13.17B |
$1.26B |
9.6% |
| 2017 |
$0.88 |
$13.69B |
$357M |
2.6% |
| 2018 |
$5.14 |
$14.51B |
$1.96B |
13.5% |
| 2019 |
$5.36 |
$27.81B |
$3.31B |
11.9% |
| 2020 |
$3.92 |
$25.29B |
$2.42B |
9.6% |
| 2021 |
$6.87 |
$28.59B |
$4.54B |
15.9% |
| 2022 |
$1.61 |
$30.15B |
$1.1B |
3.7% |
| 2023 |
$-0.93 |
$29.65B |
$-608M |
-2.1% |
| 2024 |
$-9.30 |
$29.21B |
$-6.19B |
-21.2% |
